Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.20.2
Consolidated Balance Sheets - USD ($)
Apr. 30, 2020
Jan. 31, 2020
Current Assets    
Undeposited Funds $ 15
Inventory 15
Total current assets 30
Total assets 30 0
Current liabilities    
Accounts payable and accrued expenses - related party 42,307 48,940
Accounts payable related party 119,602 254,495
Due to Related Party 311,176 304,072
Total current liabilities 473,085 607,507
Total Liabilities 473,085 607,507
Stockholders equity    
Series A Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 150,000 and 0 shares issued and outstanding, as of April 30, 2020 and January 31, 2020, respectively. 15
Series B Preferred stock, $0.0001 par value; 1,000,000 shares authorized; 650,000 and 0 shares issued and outstanding, as of April 30, 2020 and January 31, 2020, respectively. 65
Common stock, $0.0001 par value, voting; 200,000,000 shares authorized; 5,706,317 and 10,460,000 shares issued and outstanding, as of April 30, 2020 and January 31, 2020, respectively. 571 1,046
Additional paid in capital 51,853,707 3,500,892
Accumulated deficit (52,327,413) (4,109,445)
Total stockholders equity (473,055) (607,507)
Total liabilities and stockholders equity $ 30 $ 0